Globe Newswire
Recommendation for adults with uncontrolled COPD with raised blood eosinophils based on data from two landmark Phase 3 trials demonstrating Dupixent significantly reduced exacerbations and improved lung function
If approved, Dupixent would be the first-ever targeted therapy for COPD in the EU and the first new treatment approach for this disease in more than a decade
TARRYTOWN, N.Y. and PARIS, May 31, 2024 (GLOBE NEWSWIRE) --... (continue reading...)
Dupixent recommended for EU approval by the CHMP to treat patients with COPD
- Recommendation for adults with uncontrolled COPD with raised blood eosinophils based on data from two landmark Phase 3 trials demonstrating Dupixent significantly reduced exacerbations and improved lung function
- If approved, Dupixent would be the first-ever targeted therapy for COPD in the EU and the first new treatment approach for this disease in more than a decade
Paris and Tarrytown,... (continue reading...)
The net asset value (NAV) of EfTEN United Property Fund unit was 10.70 euros at the end of April, increasing by 0.9% over the month. The jump in NAV was related to the investment of the listed fund EfTEN Real Estate Fund AS, whose shares closed on the Tallinn stock exchange at 4% higher than a month ago. The fund's return on unlisted investments was on average 0,4% in April.
In May, EfTEN United Property Fund invested 255 thousand euros in the EfTEN Residential Fund,... (continue reading...)
PRESS RELEASE – REGULATED INFORMATION
Mont-Saint-Guibert, Belgium, May 31, 2024, 7.00 am CEST – BIOSENIC (Euronext Brussels and Paris: BIOS), the clinical-stage company specializing in serious autoimmune and inflammatory diseases and cell therapy, today announces an increase in the total number of voting rights and shares as a result of the issuance of new shares. The following information is published in accordance with Article 15 of the Belgian law of 2 May 2007... (continue reading...)
More Globe Newswire
View Older Stories-
Press Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with type 2 inflammation
-
Start of Day Message
-
Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type 2 Inflammation
-
Dividend payment ex-date of AS Merko Ehitus is 7 June 2024
-
Issue of Additional Tier 1 Temporary Write-Down Notes
-
Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024
-
VEON discloses April YTD trading update at its AGM
-
Data from the PRECISION study of aprocitentan to be presented at the European Society of Hypertension Annual Meeting 2024
-
Mowi ASA (OSE: MOWI): 2024 Salmon Farming Industry Handbook
-
Sen. John Cornyn delivers remarks at Driscoll Children's Hospital Rio Grande Valley
-
Sen. John Cornyn delivers remarks at Driscoll Children's Hospital Rio Grande Valley
-
Renault Group: Renault Group and Geely announce the creation of leading Powertrain Technology Company, “HORSE Powertrain Limited”
-
Flash News: OKX to List Ultiverse's Token on its Spot Market, Expanding Trading Options
-
Avaada Energy Secures 1050 MWp Solar Project in NTPC Auction; Crosses over 15 GWp Portfolio in India
-
Clip Money Inc. Reports First Quarter 2024 Results
-
CloudMD Reports First Quarter 2024 Results
-
United States Government to Reinstate Section 301 Import Tariffs on Artificial Graphite from China
-
Lowey Dannenberg, P.C. is Investigating Akero Therapeutics, Inc. (“Akero”) (NASDAQ: AKRO) for Potential Violations of the Federal Securities Laws and Encourages Investors with Losses to Contact th
-
ENPHASE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Enphase Energy, Inc. and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Intel, AXT, and Li Auto and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sprout Social, Inari, and Cambium and Encourages Investors to Contact the Firm
-
Canadian Spirit Resources Inc. Announces Third Quarter March 31, 2024 Financial Results
-
-
POSCO and Hazer Collaborate on Clean Hydrogen Production Technology for Low Carbon Steel
-
Pineapple Energy Announces Appointment of Chief Operating Officer
-
A year of partnerships to drive sustainability in Canadian agriculture
-
San Diego County Regional Public Safety Agencies Launch Genasys EVAC for Enhanced Emergency Communication
-
NowVertical Group Reports First Quarter 2024 Financial Results
-
Syncromune, Inc. Announces FDA Clearance of IND Application for SYNC-T SV-102, a First-In-Class Combination Multi-Target Immunotherapy for Metastatic Castrate-Resistant Prostate Cancer
-
ELS LOSS ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Equity LifeStyle Properties, Inc. Investors to Inquire About Securities Class Action Investigation – ELS
-
Perseus provides update on Nyanzaga Gold Project
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Autodesk, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ADSK
-
Patagonia Gold Quarter 1 2024 Financial Results
-
Telix Announces Positive rPFS Data from ProstACT SELECT Trial of TLX591 rADC Therapy Candidate in Prostate Cancer
-
ValOre Metals Corp. Announces Voting Results of Annual General Meeting
-
Hydreight Reports Record Topline(1) Revenue of $4.87M in Q1-2024 (YOY Increase of 33%)
-
Media Alert: Newsweek Senior Writer Available to Discuss Trump Verdict
-
Lowey Dannenberg, P.C. is Investigating Masimo Corporation (NASDAQ: MASI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact t
-
Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024
-
Central 1 reports 2024 first quarter financial results
-
Novartis Phase III data confirm sustained efficacy and long-term safety of oral remibrutinib in chronic spontaneous urticaria
-
Petrus Resources Announces Monthly Activity Update
-
Vytelle Announces Expansion Plans to Melbourne, Australia with its Twenty-First Global Bovine In Vitro Fertilization Laboratory
-
Goodness Growth Holdings to Complete Non-Brokered Private Placement to Support the Relocation of a Minnesota Dispensary
-
Plug to Webcast Annual Shareholder Meeting on June 5, 2024
-
QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications
-
Rakovina Therapeutics Announces 2024 Q1 Financial Results and Provides Corporate Update
-
HashiCorp Announces First Quarter of Fiscal Year 2025 Financial Results
-
Oak Valley Bancorp Honored with the 2023 Raymond James Community Bankers Cup Award
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages AST SpaceMobile, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ASTS